See more : Vishnu Chemicals Limited (VISHNU.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Genky DrugStores Co., Ltd. (9267.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Genky DrugStores Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Galenica AG (GALNF) Income Statement Analysis – Financial Results
- CollPlant Biotechnologies Ltd. (CLGN) Income Statement Analysis – Financial Results
- Mytrex Health Technologies, Inc. (4431.TWO) Income Statement Analysis – Financial Results
- Amata VN Public Company Limited (AMATAV.BK) Income Statement Analysis – Financial Results
- Patagonia Gold Corp. (HGLD) Income Statement Analysis – Financial Results
Genky DrugStores Co., Ltd. (9267.T)
About Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 184.86B | 169.06B | 154.64B | 142.38B | 123.60B | 103.90B | 94.87B | 83.40B | 73.50B | 63.14B | 57.95B | 54.66B | 56.70B | 51.52B | 41.25B | 36.93B | 32.73B |
| Cost of Revenue | 147.24B | 134.51B | 123.69B | 112.09B | 96.89B | 79.48B | 72.97B | 63.97B | 57.30B | 49.27B | 45.84B | 43.87B | 44.94B | 40.79B | 32.48B | 28.95B | 25.74B |
| Gross Profit | 37.62B | 34.55B | 30.95B | 30.29B | 26.71B | 24.42B | 21.90B | 19.42B | 16.19B | 13.87B | 12.11B | 10.79B | 11.76B | 10.73B | 8.77B | 7.97B | 6.99B |
| Gross Profit Ratio | 20.35% | 20.44% | 20.02% | 21.27% | 21.61% | 23.50% | 23.08% | 23.29% | 22.03% | 21.97% | 20.89% | 19.74% | 20.73% | 20.83% | 21.25% | 21.59% | 21.36% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 22.37B | 20.37B | 17.77B | 15.58B | 13.54B | 11.13B | 10.20B | 9.89B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 2.08B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 28.61B | 23.19B | 21.00B | 19.91B | 22.37B | 20.37B | 17.77B | 15.58B | 13.54B | 11.13B | 10.20B | 9.89B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 431.00M | 436.82M | 352.32M | 275.88M | 293.98M | 308.37M | 286.95M | 281.20M | 187.27M | 157.40M | 195.67M | 446.81M | 413.97M | 314.08M | 151.85M | 107.21M |
| Operating Expenses | 28.72B | 27.84B | 25.28B | 23.99B | 22.37B | 20.37B | 17.77B | 15.58B | 13.54B | 11.13B | 10.20B | 9.89B | 10.08B | 9.38B | 7.80B | 7.02B | 5.82B |
| Cost & Expenses | 175.84B | 162.35B | 148.96B | 136.08B | 119.26B | 99.85B | 90.74B | 79.55B | 70.84B | 60.40B | 56.05B | 53.76B | 55.03B | 50.17B | 40.28B | 35.98B | 31.56B |
| Interest Income | 7.00M | 8.00M | 9.01M | 9.92M | 10.30M | 13.76M | 15.90M | 15.74M | 16.75M | 18.00M | 17.56M | 13.80M | 9.90M | 7.86M | 6.76M | 5.78M | 4.78M |
| Interest Expense | 103.00M | 70.00M | 59.09M | 55.52M | 61.73M | 49.40M | 40.50M | 61.97M | 69.89M | 66.36M | 69.17M | 65.73M | 47.92M | 48.74M | 59.96M | 66.06M | 69.55M |
| Depreciation & Amortization | 5.57B | 4.96B | 4.59B | 4.06B | 3.76B | 3.32B | 2.91B | 2.61B | 2.19B | 1.55B | 1.45B | 1.36B | 1.17B | 1.04B | 869.18M | 723.04M | 496.66M |
| EBITDA | 14.47B | 11.73B | 10.73B | 10.78B | 7.86B | 7.26B | 7.29B | 6.77B | 5.13B | 4.46B | 3.52B | 2.44B | 3.28B | 2.69B | 2.09B | 1.77B | 1.78B |
| EBITDA Ratio | 7.83% | 7.16% | 6.93% | 7.53% | 6.79% | 7.39% | 7.72% | 8.11% | 7.00% | 7.12% | 6.09% | 4.50% | 5.82% | 5.46% | 5.22% | 4.96% | 5.44% |
| Operating Income | 9.02B | 6.71B | 5.68B | 6.29B | 4.34B | 4.05B | 4.13B | 3.85B | 2.66B | 2.74B | 1.90B | 896.56M | 1.67B | 1.35B | 964.44M | 950.45M | 1.17B |
| Operating Income Ratio | 4.88% | 3.97% | 3.67% | 4.42% | 3.51% | 3.90% | 4.35% | 4.62% | 3.61% | 4.34% | 3.28% | 1.64% | 2.95% | 2.62% | 2.34% | 2.57% | 3.58% |
| Total Other Income/Expenses | -213.00M | -5.00M | 408.77M | 368.02M | -309.60M | -160.59M | 210.55M | 240.92M | 211.65M | 102.74M | 92.42M | 120.26M | 133.03M | 251.20M | 195.07M | 34.04M | 376.89M |
| Income Before Tax | 8.80B | 6.70B | 6.08B | 6.66B | 4.03B | 3.89B | 4.34B | 4.09B | 2.87B | 2.84B | 1.99B | 1.02B | 2.06B | 1.60B | 1.16B | 984.50M | 1.55B |
| Income Before Tax Ratio | 4.76% | 3.97% | 3.93% | 4.68% | 3.26% | 3.74% | 4.57% | 4.90% | 3.90% | 4.50% | 3.44% | 1.86% | 3.63% | 3.11% | 2.81% | 2.67% | 4.73% |
| Income Tax Expense | 2.48B | 1.94B | 1.66B | 1.83B | 1.28B | 1.19B | 1.22B | 1.24B | 965.56M | 1.08B | 822.89M | 393.75M | 912.53M | 697.94M | 503.41M | 504.29M | 647.77M |
| Net Income | 6.32B | 4.76B | 4.42B | 4.83B | 2.76B | 2.70B | 3.12B | 2.85B | 1.90B | 1.76B | 1.17B | 623.07M | 1.14B | 904.22M | 656.10M | 480.20M | 900.73M |
| Net Income Ratio | 3.42% | 2.82% | 2.86% | 3.39% | 2.23% | 2.60% | 3.29% | 3.41% | 2.59% | 2.79% | 2.02% | 1.14% | 2.02% | 1.76% | 1.59% | 1.30% | 2.75% |
| EPS | 207.94 | 156.89 | 145.59 | 159.15 | 90.76 | 87.35 | 103.26 | 100.87 | 67.47 | 63.05 | 42.38 | 22.60 | 41.62 | 32.92 | 26.45 | 19.69 | 7.39K |
| EPS Diluted | 207.91 | 156.79 | 145.44 | 159.01 | 90.76 | 87.35 | 103.26 | 100.87 | 67.47 | 62.55 | 41.88 | 22.32 | 41.04 | 32.67 | 26.28 | 19.58 | 7.29K |
| Weighted Avg Shares Out | 30.41M | 30.38M | 30.39M | 30.38M | 30.35M | 30.88M | 30.19M | 28.20M | 28.18M | 28.15M | 27.96M | 27.91M | 27.49M | 27.46M | 24.81M | 24.39M | 25.41M |
| Weighted Avg Shares Out (Dil) | 30.42M | 30.39M | 30.40M | 30.38M | 30.35M | 30.88M | 30.19M | 28.20M | 28.18M | 28.16M | 27.96M | 27.91M | 27.88M | 27.68M | 24.97M | 24.39M | 25.41M |
No news found for: 9267.T
Source: https://incomestatements.info
Category: Stock Reports